49 results
8-K
EX-99.2
PRAX
Praxis Precision Medicines Inc
17 Mar 21
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
7:17am
-19 pandemic on Praxis’ business, operations, clinical trials, supply chain, strategy, goals and anticipated timelines. Except as required … ) uncertainties and assumptions regarding the impact of the COVID-19 pandemic on Praxis’ business, operations, clinical trials, supply chain, strategy, goals
8-K
EX-99.1
c9bqhhun7bt9lj3kpfl
8 Aug 22
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:04pm
10-Q
t2pz6if23jl0ylwu3
23 Nov 20
Quarterly report
4:16pm
DEFA14A
ubxstqt10fzfx8 srmr
23 May 22
Additional proxy soliciting materials
9:05am
10-K
ht5wpiohaak
17 Mar 21
Annual report
8:33am
8-K
gsmhc emc44o8wa
10 Jan 22
Regulation FD Disclosure
4:52pm
S-1/A
0wsxqv90hjj774nrz1z
9 Oct 20
IPO registration (amended)
6:09am
424B4
jh02bclmpbqqxmn
16 Oct 20
Prospectus supplement with pricing info
4:02pm
8-K
EX-99.3
kwkjwrmkammv7uy wq16
9 May 22
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:04pm
S-1
fdjl3qdbltk9dr1py
25 Sep 20
IPO registration
5:19pm
8-K
EX-99.1
ryd i8i1k
10 Jan 22
Regulation FD Disclosure
4:52pm
8-K
EX-99.2
nuvnc
28 Feb 22
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
6:06am